The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.

Abroad (travel likely)RecruitingPHASE2

Conditions

Diabetic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Steno Diabetes Center Copenhagen, Copenhagen, Copenhagen, Denmark
Contact: Study coordinator (Peter Rossing, Professor) · Peter.Rossing@regionh.dk · +30913383

Study leads

Peter Rossing, dr.med.
Principal Investigator
Steno Diabetes Center Copenhagen

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD)

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Little Rock, United States

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetic Kidney Disease · Type 1 Diabetes

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Seattle, United States

NAD Augmentation in Diabetes Kidney Disease

Type2diabetes · Diabetic Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Boston, United States

A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Diabetic Kidney Disease

Abroad (travel likely)RecruitingPHASE1

Beijing, China